Psychometric Evaluation of the Short Patient Evaluation Questionnaire
A Prospective Multi Center Prospective Cross-sectional and Longitudinal Study to Evaluate the Psychometric Properties of the Short Patient Evaluation Questionnaire
1 other identifier
observational
250
0 countries
N/A
Brief Summary
It is important for physiotherapy in general and for the individual physio-therapist to demonstrate the result of the interventions in physiotherapy. The new short (4 items) generic questionnaire Short Patient Evaluation Questionnaire SPEQ was especially developed for use in private practices to answer the main questions for evaluation of treatment. This research project aims at evaluating the reliability, validity and responsiveness of the SPEQ and at providing an estimate for Minimal Important Difference MID that may be used as threshold for clinical relevant changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2017
CompletedFirst Posted
Study publicly available on registry
March 12, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedMarch 12, 2019
March 1, 2019
Same day
August 15, 2017
March 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Test Retest reliability of SPEQ
Intra-Class Correlation coefficient (using a two way random effects model)
up to 30 weeks
Accuracy of the SPEQ
analysis of accuracy of SPEQ to detect patients who changed in transition question with ROC analysis
up to 30 weeks
Criterion Validity
The validity will be assessed using hypothesis testing of correlations (between SPEQ and existing previously validated measures). The SPEQ has a sufficient criterion validity, if these correlations are at least moderate (rho\>0.5)
up to 30 weeks
Secondary Outcomes (4)
Inner consistancy
up to 30 weeks
Construct validity of the SPEQ
up to 30 weeks
Responsiveness of the SPEQ
up to 30 weeks
Validity of the SPEQ as assessed using Spearman correlations with scores of other previously validated measures
up to 30 weeks
Other Outcomes (3)
Smallest sum of the proportions of misclassification
up to 30 weeks
Distribution based Minimal Important Difference
up to 30 weeks
Anchor based Minimal Important Difference
up to 30 weeks
Study Arms (1)
intervention
any kind of condition treated by physiotherapists, physical therapy treatment is chosen by treating physiotherapist
Interventions
Eligibility Criteria
The study population will consist of the regular patient in full age in physical therapy treatment without a grave other health problems, that may interfere with the result of the treatment with physiotherapy
You may qualify if:
- Persons older than 18 years, that are in physical therapy treatment.
- Persons must be able to read and understand German.
You may not qualify if:
- Grave cognitive changes
- Bedridden patients
- Grave comorbidities that may interfere with the treatment with physical therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nanco van der Maaslead
- Insel Gruppe AG, University Hospital Berncollaborator
- HES-SO Valais-Walliscollaborator
- University of Berncollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nico van der Maas
Institut für Physiotherapieforschung gmbh, Biel, Switzerland
- PRINCIPAL INVESTIGATOR
Martin Verra, PHD
Institute of physiotherapy, Insel university hospital, Bern, Switzerland
- PRINCIPAL INVESTIGATOR
Roger Hilfiger, MSc.
HES-SO Valais/Wallis, Leukerbad, Switzerland
- PRINCIPAL INVESTIGATOR
Angela Balsimann Schwarz, MSc.
Bern university of applied sciences, Health professions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
August 15, 2017
First Posted
March 12, 2019
Study Start
June 1, 2019
Primary Completion
June 1, 2019
Study Completion
October 1, 2019
Last Updated
March 12, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share